Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

03 juin 2024 08h00 HE | Source: Rumi Scientific, Inc.

RUMI Scientific announces Receipt of Two-Year Phase II SBIR Award totaling $1.9 Million to Accelerate Discovery and Development of Novel Therapeutic Candidates for the Treatment of Autism

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- RUMI Scientific, Inc. (“RUMI”) a developer of therapies for rare and neurodegenerative diseases using its high throughput organoid phenotypic screening...
05 déc. 2023 08h00 HE | Source: Rumi Scientific, Inc.

Rumi Scientific Announces Partnership with X-Chem for Development of Lead Candidate in Huntington’s Disease

NEW YORK, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Rumi Scientific (“Rumi”), a developer of therapies for rare and neurodegenerative diseases using its high throughput organoid phenotypic screening...
26 avr. 2023 07h05 HE | Source: Rumi Scientific, Inc.

Rumi Scientific Announces Data Demonstrating Disease Modifying Effect of BRD9 Inhibition in a Huntington’s Disease Animal Model

NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Rumi Scientific (“Rumi”), a developer of therapies for rare and neurodegenerative diseases discovered using its high throughput organoid phenotypic...
30 mars 2023 08h00 HE | Source: Rumi Scientific, Inc.

Rumi Scientific Appoints Allen A. Fienberg, Ph.D., as Chief Executive Officer and Chairman of the Board of Directors

NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- Rumi Scientific (“Rumi”), a developer of therapies for rare and neurodegenerative diseases discovered using its high throughput organoid phenotypic...